GeoVax to Unveil Mpox Vaccine Progress at Emerging Growth Conference
GeoVax Labs announces updates on its GEO-MVA Mpox vaccine at the Emerging Growth Conference, highlighting advancements in vaccine development and pandemic readiness.
The development of GeoVax's GEO-MVA vaccine represents a critical step forward in global health security, offering a promising solution to combat Mpox and enhance pandemic preparedness. This news is particularly relevant for investors, healthcare professionals, and policymakers focused on advancing vaccine technology and ensuring broad access to life-saving immunizations.
